We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Breast Tumor Localization Implant Removes Time Constraints

By HospiMedica International staff writers
Posted on 29 Nov 2017
Image: The Savi Scout surgical guidance system (Photo courtesy of Cianna Medical).
Image: The Savi Scout surgical guidance system (Photo courtesy of Cianna Medical).
A novel non-radioactive breast tumor localization system used can be implanted with no restrictions on the length of time the reflector can remain in the breast.

The Cianna Medical (Aliso Viejo, CA, USA) Savi Scout breast tumor localization system uses electromagnetic (EM) wave technology to provide real-time audible and visual indicators for target tissue acquisition during breast conservation procedures, with a 360˚ detection capability and a pinpoint accuracy of one millimeter. The system is based on a passive reflector placed in the target tissue prior to surgery by an interventional radiologist. During the procedure, the surgeon uses a special handpiece that emits EM radar waves to locate the reflector and plan the incision.

The reflector is completely passive until activated, allowing patients to continue with all activities; and because it does not interfere with magnetic resonance imaging (MRI) scans, it provides physicians with maximum flexibility for its localization at any time during the continuum of care. During the lumpectomy or surgical biopsy, the surgeon scans the breast using the Scout guide, which emits 50 million pulses per second, in order to lock on to the reflector’s position. The reflector and target tissue can then be safely removed.

“I applaud the vision of all our physicians and health systems who are leading the way in offering a new standard of care in breast tumor localization,” said Jill Anderson, President and CEO of Cianna Medical. “Scout has become the most precise and broadly applicable non-wire localizing system in the industry, and more than 170 leading medical centers across the United States have adopted Scout radar breast localization and surgical guidance system as an alternative to placing wires on the day of surgery.”

The standard preoperative technique for localizing non-palpable breast lesions, developed more than 20 years ago, is wire localization, which involves a radiopaque wire inserted into the breast by a radiologist prior to surgery using mammography or ultrasound guidance. The surgeon can subsequently be guided directly to the target tissue.

Related Links:
Cianna Medical

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Short Phlebotomy Cart
MSWA-3469-WHT
New
Hemostatic Agent
HEMOBLAST Bellows

Channels

Critical Care

view channel
Image: The skin-like sensor monitors internal and external body movement, and electrical signals (Photo courtesy of Huanyu “Larry” Cheng and Jennifer M. McCann)

Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery

Medical conditions such as bladder control issues and the need for monitoring vital signs after surgery require precise, long-term tracking to improve patient outcomes. These conditions can be challenging... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more